What Researchers Did
Researchers studied 60 patients with sudden deafness, giving one group hyperbaric oxygen therapy (HBOT) combined with medical treatment and another group HBOT alone, comparing their outcomes to 30 healthy individuals.
What They Found
The group receiving HBOT combined with medical treatment showed a significant improvement in hearing (P < 0.05) and beneficial changes in serum markers like superoxide dismutase (SOD) and malondialdehyde (MDA) compared to baseline and the HBOT-only group. Specifically, SOD levels significantly improved in the combined treatment group (P 0.05). The study concluded that HBOT alone did not provide a satisfactory curative effect for sudden deafness.
What This Means for Canadian Patients
This study suggests that for sudden deafness, HBOT might be more effective when used alongside other medical treatments rather than as a standalone therapy. Canadian patients experiencing sudden deafness should discuss comprehensive treatment options with their healthcare providers, as HBOT alone may not be sufficient.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The abstract does not provide specific details on the hyperbaric oxygen therapy protocol used, such as pressure or number of sessions, which limits the ability to replicate or compare findings.